SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001358403-20-000012
Filing Date
2020-04-27
Accepted
2020-04-27 15:34:36
Documents
5
Period of Report
2020-06-15
Effectiveness Date
2020-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2020proxydefinitive.htm DEF 14A 929302
2 bellicumpressrel_image1a01.gif GRAPHIC 21803
3 bellicumproxycard001.gif GRAPHIC 45222
4 bellicumproxycard002.gif GRAPHIC 79047
5 bellicumproxycard003.gif GRAPHIC 48908
  Complete submission text file 0001358403-20-000012.txt   1199463
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36783 | Film No.: 20819753
SIC: 2834 Pharmaceutical Preparations